Your browser doesn't support javascript.
loading
MCL1 as a therapeutic vulnerability in Burkitt lymphoma.
Yuan, Ren; Wang, Michelle Y; Bi, Chengfeng; Zhao, Xiaohong; Tao, Jianguo.
Afiliação
  • Yuan R; Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA.
  • Wang MY; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Bi C; Department of Pathology, University of Nebraska Medical Center, Omaha, NE, 68198, USA.
  • Zhao X; Chemical Biology and Molecular Medicine Program, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, 33612, USA.
  • Tao J; Department of Pathology, University of Virginia Medical Center, Charlottesville, VA, 22903, USA. wrw6qu@virginia.edu.
Leukemia ; 37(4): 934-937, 2023 04.
Article em En | MEDLINE | ID: mdl-36732564
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Burkitt Idioma: En Ano de publicação: 2023 Tipo de documento: Article